DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Katz - 1 Ara Katz - 1 Eran Segal - 1 Eric Topol - 1 transcriptome - 1 Katz's - 1 Raja Dhir - 1 Dhir - 1
Top related locs:
Top related orgs:
Seed - 1 Seed Health - 1 CNBC - 1 Weizmann Institute of Science - 1 Scripps Research Institute - 1 UCLA - 1 Luskin Microbiome - 1 Baylor College of Medicine - 1

Search resuls for: "Seed Health"


2 mentions found


☆ Biotech startup Seed Health is betting its profits on AI-powered medical science
  + stars: | 2024-04-11 | by ( Natalie Rose Goldberg | ) www.cnbc.com   time to read: +7 min
On Thursday, Seed Health launched CODA, a computational biology platform funded by its consumer business profitability. Seed Health has been in the business of microbiome scientific breakthroughs since its founding in 2015, but its biggest success to-date may have been becoming profitable as a bioscience startup. Katz's co-founder and co-CEO at Seed Health, Raja Dhir, said CODA and the accompanying data set will help to standardize microbiome science methods, which has long been an issue in the field. CODA's first applications are in metabolic health, brain health, longevity, and menopause, research areas chosen because they have already been identified as areas of human health where early CODA data displayed the strongest evidence. Seed Health has been working on several efforts around pioneering microbiome science for human and planetary health, and many in the field believe the approach is destined to have wider applications.
Persons: Katz, Ara Katz, Eran Segal, Eric Topol, transcriptome, Katz's, Raja Dhir, Dhir, Arpana Gupta, Goodman, There's, Segal, Joseph Petrosino, Petrosino Organizations: Seed, Seed Health, CNBC, Weizmann Institute of Science, Scripps Research Institute, UCLA, Luskin Microbiome, Baylor College of Medicine, Center, Metagenomics, Microbiome Research
☆ See the presentations that cutting-edge biotech companies have used to raise millions from top investors
  + stars: | 2022-09-22 | by ( Leah Rosenbaum | ) www.businessinsider.com   time to read: +6 min
Funding for biotech companies soared in 2021 to nearly $47 billion — a record for the industry. Insider rounded up all the biotech pitch decks we've published, from those seeking early-stage funding to presentations for late-stage rounds, that have helped companies raise money from investors. Here's the 24-slide pitch deck the company used to raise $175 million from investors like Leaps by Bayer. Here is the 24-slide pitch deck the company used to raise $120 million and prepare for regulatory approval in Japan. In late-stage funding rounds, the investors might also be different or used to backing bigger companies.
0 next >>
Total: 2